MA (EU) number 
(Invented) 
name 
Strength 
Pharmaceutical 
Form 
Route of 
Administration 
Immediate 
Packaging 
Content 
(concentration) 
Pack size 
EU/1/18/1326/001  Flucelvax Tetra 
--¹ 
EU/1/18/1326/002  Flucelvax Tetra 
--¹ 
EU/1/18/1326/003  Flucelvax Tetra 
--¹ 
EU/1/18/1326/004  Flucelvax Tetra 
--¹ 
Suspension for 
injection 
Suspension for 
injection 
Suspension for 
injection 
Suspension for 
injection 
Intramuscular use  Pre-filled syringe 
0.5 ml 
(glass) without 
needle 
10 pre-filled 
syringes  
Intramuscular use  Pre-filled syringe 
0.5 ml 
1 pre-filled syringe  
(glass) with 
needle 
Intramuscular use  Pre-filled syringe 
0.5 ml 
(glass) with 
needle 
10 pre-filled 
syringes  
Intramuscular use  Pre-filled syringe 
0.5 ml 
1 pre-filled syringe  
(glass) without 
needle 
--¹  1 Each 0.5 ml dose contains: 
Influenza virus surface antigens (haemagglutinin and neuraminidase)*, inactivated, of the following strains: 
A/Wisconsin/67/2022 (H1N1)pdm09-like strain (A/Georgia/12/2022 CVR-167) 15 micrograms HA** 
A/Darwin/6/2021 (H3N2)-like strain (A/Darwin/11/2021, wild type) 15 micrograms HA** 
B/Austria/1359417/2021-like strain (B/Singapore/WUH4618/2021, wild type) 15 micrograms HA** 
B/Phuket/3073/2013-like strain (B/Singapore/INFTT-16-0610/2016, wild type) 15 micrograms HA** 
per 0.5 ml dose 
* propagated in Madin Darby Canine Kidney (MDCK) cells 
** haemagglutinin 
 
 
 
  
 
 
 
 
